BD Biosciences & CSIR-IGIB inaugurate India’s first Centre of Excellence for Single-Cell Multiomics

The new centre is expected to support applications across areas such as cancer biology, immune profiling, and molecular medicine, where fine-grained cellular insights are critical.

BD Life Sciences-Biosciences, part of global medical technology company BD (Becton, Dickinson and Company), has inaugurated India’s first Centre of Excellence for Single-Cell Multiomics in collaboration with the CSIR-Institute of Genomics and Integrative Biology (IGIB).

The initiative has brought advanced single-cell multiomics technologies into an integrated research setting within a public scientific institution, with the aim of enabling deeper, data-driven understanding of cellular systems relevant to human health.

The Centre of Excellence has been designed as a collaborative platform that combines BD’s Rhapsody Single Cell Analysis Solutions with IGIB’s established strengths in high-throughput next-generation sequencing and bioinformatics.

“The centre will help researchers translate complex biological data into real-world healthcare solutions, aligned with the company's mission of advancing global health,” said Atul Grover, Managing Director, BD India and South Asia.

By integrating experimental multiomics data with computational analysis, the centre seeks to support research that can decode complex cellular behaviour at unprecedented resolution.

This approach is increasingly central to modern digital health and precision medicine, where biological insights are translated into targeted diagnostics and therapies.

Dr Souvik Maiti, Director of CSIR-IGIB, said, “Collaborating with BD enables us to create a platform that fosters innovation and supports national priorities in genomics, molecular medicine and bioinformatics.”

Single-cell multiomics allows researchers to study genomic, transcriptomic, and other molecular layers within individual cells. When paired with advanced bioinformatics, these datasets can reveal how cellular diversity drives immunity, disease progression, and treatment response.

The new centre is expected to support applications across areas such as cancer biology, immune profiling, and molecular medicine, where fine-grained cellular insights are critical.

Dr Rajesh Pandey, Principal Scientist at CSIR-IGIB, described the initiative as an important step in building a sustainable ecosystem for single-cell multiomics research in the country.

Beyond this newly launched facility, BD Biosciences has already established multiple Centres of Excellence across India, including the BD-NCBS CoE in Advanced Flow Cytometry in Bengaluru, the BD-CMC Vellore CoE in Clinical Flow Cytometry, the BD-JH FACS Academy, and the BD-Sehgal Path Lab CoE in Mumbai.

Stay tuned for more such updates on Digital Health News